Copy number alteration burden predicts prostate cancer relapse
H Hieronymus, N Schultz, A Gopalan… - Proceedings of the …, 2014 - National Acad Sciences
Primary prostate cancer is the most common malignancy in men but has highly variable
outcomes, highlighting the need for biomarkers to determine which patients can be …
outcomes, highlighting the need for biomarkers to determine which patients can be …
[PDF][PDF] Copy number alteration burden predicts prostate cancer relapse
H Hieronymusa, N Schultzb, A Gopaland, BS Carvere… - PNAS, 2014 - sys.91sqs.net
Term Clinical Follow-Up. To generate an independent cohort of prostate cancer patients with
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
[HTML][HTML] Copy number alteration burden predicts prostate cancer relapse
H Hieronymus, N Schultz, A Gopalan… - Proceedings of the …, 2014 - ncbi.nlm.nih.gov
Term Clinical Follow-Up. To generate an independent cohort of prostate cancer patients with
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
[PDF][PDF] Copy number alteration burden predicts prostate cancer relapse
H Hieronymusa, N Schultzb, A Gopaland, BS Carvere… - PNAS, 2014 - researchgate.net
Term Clinical Follow-Up. To generate an independent cohort of prostate cancer patients with
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
Copy number alteration burden predicts prostate cancer relapse.
H Hieronymus, N Schultz, A Gopalan… - Proceedings of the …, 2014 - europepmc.org
Term Clinical Follow-Up. To generate an independent cohort of prostate cancer patients with
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
[PDF][PDF] Copy number alteration burden predicts prostate cancer relapse
H Hieronymusa, N Schultzb, A Gopaland, BS Carvere… - PNAS, 2014 - academia.edu
Term Clinical Follow-Up. To generate an independent cohort of prostate cancer patients with
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
Copy number alteration burden predicts prostate cancer relapse
H Hieronymus, N Schultz, A Gopalan… - Proceedings of the …, 2014 - pubmed.ncbi.nlm.nih.gov
Primary prostate cancer is the most common malignancy in men but has highly variable
outcomes, highlighting the need for biomarkers to determine which patients can be …
outcomes, highlighting the need for biomarkers to determine which patients can be …
Copy number alteration burden predicts prostate cancer relapse
H Hieronymus, N Schultz, A Gopalan… - Proceedings of the …, 2014 - cir.nii.ac.jp
抄録< jats: title> Significance</jats: title>< jats: p> Prostate cancer is a major health burden
with significant overtreatment because of difficulty segregating high-and low-risk disease …
with significant overtreatment because of difficulty segregating high-and low-risk disease …
Copy number alteration burden predicts prostate cancer relapse
H Hieronymus, N Schultz, A Gopalan… - Proceedings of the …, 2014 - ui.adsabs.harvard.edu
Prostate cancer is a major health burden with significant overtreatment because of difficulty
segregating high-and low-risk disease. Discovery of biomarkers that stratify risk could have …
segregating high-and low-risk disease. Discovery of biomarkers that stratify risk could have …
[PDF][PDF] Copy number alteration burden predicts prostate cancer relapse
H Hieronymusa, N Schultzb, A Gopaland, BS Carvere… - PNAS, 2014 - academia.edu
Term Clinical Follow-Up. To generate an independent cohort of prostate cancer patients with
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …
molecular and clinical follow-up data, we analyzed genome-wide CNAs in 104 …